L
Luye Pharma Group
Sustainability Report and Carbon Intensity Rankings
Is Luye Pharma Group doing their part?
Their DitchCarbon score is 48
Luye Pharma Group has a DitchCarbon Score of 48 out of 100, indicating a moderate level of sustainability in their operations. This score reflects the company’s carbon intensity, suggesting there is significant room for improvement in reducing emissions. A higher score would demonstrate a stronger commitment to lowering carbon intensity and enhancing environmental sustainability.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Luye Pharma Group is part of the industrial manufacturing sector, which has a carbon intensity ranking of very low. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Unknown
High
Very high
Luye Pharma Group, located in China, operates in a region with a specific carbon intensity rating. The sustainability of the company’s operations is influenced by China’s overall carbon intensity, affecting its environmental impact.
Unlock 30+ emissions data points on Luye Pharma Group
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Luye Pharma Group
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
6.71%
...this company is doing 6.71% better in emissions than the industry average.
Luye Pharma Group Ltd., founded in 1994 and headquartered in Shanghai, operates within the industrial manufacturing sector, specifically in pharmaceuticals. The company specializes in research and development, with a focus on therapeutic areas such as oncology, cardiovascular, metabolism, and the central nervous system. With advanced production facilities across China and branch offices globally, Luye Pharma Group was listed on the Hong Kong Stock Exchange in 2014 and employs around 4,000 professionals.
emission intelligence's platform recommendations for Luye Pharma Group
Luye Pharma Group could reduce its Scope 1 emissions by adopting best practices for the handling and disposal of chemicals and gases, potentially decreasing its emissions by 35%.
Bad news, Luye Pharma Group hasn't committed to SBTi goals
Luye Pharma Group has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is still in the process of defining clear, science-based emissions reduction targets to align with global climate action efforts.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.